Gilead Sciences to support expansion of local production capacity of Remdesivir in India
Gilead will donate a minimum of 450,000 vials of Veklury to the Government of India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Gilead Sciences
Gilead gets US FDA Accelerated Approval for Trodelvy to treat metastatic urothelial cancer
New indication marks secondFDAapproval for Trodelvy in 2021
Gilead gets US FDA nod for Trodelvy to treat metastatic triple-negative breast cancer
Trodelvy significantly reduced the risk of death by 49 per cent compared with single-agent chemotherapy in the Phase 3 ASCENT…
AbCellera, Gilead collaborate for new multi-year, multi-target antibody discovery
Expanded collaboration includes an eight-target discovery partnership leveraging AbCellera’s entire technology stack
Gilead, Novo Nordisk expand NASH clinical collaboration
Triple combination regimen to be investigated in new Phase 2b study in NASH patients with cirrhosis
Gilead, Merck sign pact to develop, commercialise long-acting HIV treatment combinations
Collaboration to focus on oral and injectable formulations of Lenacapavir and Islatravir
Healthcare industry records 103 deals worth $55.3 billion in December 2020
One big-ticket deal contributes 70.5 per cent of the total deal value in December 2020
Gilead, Galapagos amend commercialisation and development pact for Jyseleca (filgotinib)
Under the new arrangement, Galapagos will assume sole responsibility in Europe for filgotinib in RA, Gilead to receive royalties…
Gilead Sciences to acquire MYR GmbH
Gilead to acquire Hepcludex, a first-in-class entry inhibitor, for treatment of chronic hepatitis delta virus (HDV), after closing…
Gilead Sciences, AIDS Society of India survey highlights disruption in HIV care during COVID-19
Main reasons for disruption in India include travel constraints, fear of getting COVID-19